Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 78.80
+0.10 (0.13%)
At close: Feb 3, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 136.69 billion as of February 3, 2026. Its market cap has increased by 148.71% in one year.
Market Cap
136.69B
Enterprise Value
129.94B
Revenue
12.52B
Ranking
n/a
PE Ratio
106.59
Stock Price
78.80
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 136.69B, an increase of 637.30%. That is a compound annual growth rate of 31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 136.51B | 3.21% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 298.15B |
| WuXi Biologics | 148.23B |
| Sino Biopharmaceutical | 113.34B |
| Sichuan Kelun-Biotech Biopharmaceutical | 93.55B |
| Akeso | 92.94B |
| 3SBio | 57.55B |
| RemeGen | 55.53B |
| Shanghai Junshi Biosciences | 35.16B |